Gastric mucosal protection and central nervous system

Current Pharmaceutical Design

Volumn 19, Issue 1, 2013, Pages 34-39

  Gyires, Klara ^a   Németh, József ^b   Zádori, Zoltán S ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Central Mechanism; Endomorphins; Gastric Mucosal Protection; Neuropeptides; Peripheral

Indexed keywords

16,16 DIMETHYLPROSTAGLANDIN E2; ADRENOMEDULLIN; AMYLIN; BICARBONATE; CALCITONIN GENE RELATED PEPTIDE; CANNABINOID; CAROTENOID; DIPROTIN A; ENDOMORPHIN 1; ENDOMORPHIN 2; GHRELIN; HEAT SHOCK PROTEIN; HYDROGEN SULFIDE; LEPTIN; MELATONIN; MU OPIATE RECEPTOR; NEUROPEPTIDE; NEUROTENSIN; NITRIC OXIDE; OPIATE PEPTIDE; PHOSPHOLIPID; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E2; PROTIRELIN; PROTIRELIN[3 (3,3 DIMETHYLPROLINAMIDE)]; RETINOL; SOMATOSTATIN; TREFOIL PEPTIDE; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ELECTROSTIMULATION; HYPOTHALAMUS; MALE; MUCUS; NONHUMAN; PARAVENTRICULAR THALAMIC NUCLEUS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; STOMACH MUCOSA; STOMACH ULCER; VAGUS NERVE;

EID: 84873802108     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128130107     Document Type: Article

References (88)

1. Davenport HW. Why the stomach does not digest itself. Sci Am 1972; 226: 87-93.
2. Sachs G, Chang HH, Rabon E, Schackman R, Lewin M, Saccomani G. A nonelectrogenic H+ pump in plasma membranes of hog stomach. J Biol Chem 1976; 251: 7690-8.
3. Davenport HW. Is the apparent hyposecretion of acid by patients with gastric ulcer a consequence of a broken barrier to diffusion of hydrogen ions into the gastric mucosa? Gut 1965; 6: 513.
4. Bardou M, Toubouti Y, Benhaberou-Brun D, Rahme E, Barkun AN. Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther 2005; 21: 677-86.
5. Leontiadis GI, McIntyre L, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2004; CD002094.
6. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-5.
7. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995; 333: 984-91.
8. deFoneska A, Kaunitz JD. Gastroduodenal mucosal defense. Curr Opin Gastroenterol 2010; 26: 604-10.
9. Holzer P. Neural emergency system in the stomach. Gastroenterology 1998; 114: 823-39.
10. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 2008; 135: 41-60.
11. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiol Rev 2008; 88: 1547-65.
12. Allen A, Flemstrom G. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol 2005; 288: C1-19.
13. Fiorucci S, Antonelli E, Distrutti E, et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by antiinflammatory nonsteroidal drugs. Gastroenterology 2005; 129: 1210-24.
14. Fiorucci S, Distrutti E, Cirino G, Wallace JL. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 2006; 131: 259-71.
15. Stachura J, Tarnawski A, Dabros W. Apoptosis: genetically programmed physiologic cell loss in normal gastric oxyntic mucosa and in mucosa of grossly healed gastric ulcer. J Clin Gastroenterol 1993; 17 Suppl 1: S70-S77.
16. Hernandez C, Santamatilde E, McCreath KJ, et al. Induction of trefoil factor (TFF)1, TFF2 and TFF3 by hypoxia is mediated by hypoxia inducible factor-1: implications for gastric mucosal healing. Br J Pharmacol 2009; 156: 262-72.
17. Hoffmann W. Trefoil factors TFF (trefoil factor family) peptidetriggered signals promoting mucosal restitution. Cell Mol Life Sci 2005; 62: 2932-8.
18. Oyake J, Otaka M, Matsuhashi T, et al. Over-expression of 70-kDa heat shock protein confers protection against monochloramineinduced gastric mucosal cell injury. Life Sci 2006; 79: 300-5.
19. Tanaka K, Tsutsumi S, Arai Y, et al. Genetic evidence for a protective role of heat shock factor 1 against irritant-induced gastric lesions. Mol Pharmacol 2007; 71: 985-93.
20. Guth PH. Current concepts in gastric microcirculatory pathophysiology. Yale J Biol Med 1992; 65: 677-88.
21. Holzer P. Neural regulation of gastrointestinal blood flow. In: Johnson LR. Ed. Physiology of the gastrointestinal tract. 4th ed. New York: Academic Press; 2006; 817-839.
22. Holzer P. Role of visceral afferent neurons in mucosal inflammation and defense. Curr Opin Pharmacol 2007; 7: 563-9.
23. Stroff T, Plate S, Respondek M, Muller KM, Peskar BM. Protection by gastrin in the rat stomach involves afferent neurons, calcitonin gene-related peptide, and nitric oxide. Gastroenterology 1995; 109: 89-97.
24. Long D, Leonard AM, Chou SN, Ferench LA. Hypothalamus and gastric ulceration. Arch Neurol 1962; 7: 167-83.
25. Palkovits M. Interconnections between the neuroendocrine hypothalamus and the central autonomic system. Geoffrey Harris Memorial Lecture, Kitakyushu, Japan, October 1998. Front Neuroendocrinol 1999; 20: 270-95.
26. Ferguson AV, Marcus P, Spencer J, Wallace JL. Paraventricular nucleus stimulation causes gastroduodenal mucosal necrosis in the rat. Am J Physiol 1988; 255: 861-65.
27. Hierlihy LE, Wallace JL, Ferguson AV. Autonomic pathways in development of neural stimulation-induced gastric mucosal damage. Am J Physiol 1994; 266: 179-85.
28. Li L, Zhang YM, Qiao WL, Wang L, Zhang JF. Effects of hypothalamic paraventricular nuclei on apoptosis and proliferation of gastric mucosal cells induced by ischemia/reperfusion in rats. World J Gastroenterol 2007; 13: 874-81.
29. Osumi Y, Aibara S, Sakae K, Fujiwara M. Central noradrenergic inhibition of gastric mucosal blood flow and acid secretion in rats. Life Sci 1977; 20: 1407-16.
30. Garrick T, Grijalva CV, Trauner M. Lateral hypothalamic lesions cause gastric injury by stimulating gastric contractility. Am J Physiol 1993; 265: 138-42.
31. Grijalva CV, Deregnaucourt J, Code CF, Novin D. Gastric mucosal damage in rats induced by lateral hypothalamic lesions: protection by propantheline, cimetidine, and vagotomy. Proc Soc Exp Biol Med 1980; 163: 528-33.
32. Tache Y, Stephens RL, Jr., Ishikawa T. Central nervous system action of TRH to influence gastrointestinal function and ulceration. Ann N Y Acad Sci 1989; 553: 269-85.
33. Kiraly A, Suto G, Tam B, Hermann V, Mozsik G. Vagus-mediated activation of mucosal mast cells in the stomach: effect of ketotifen on gastric mucosal lesion formation and acid secretion induced by a high dose of intracisternal TRH analogue. J Physiol Paris 2000; 94: 131-4.
34. Okumura T, Uehara A, Watanabe Y, Taniguchi Y, Kitamori S, Namiki M. Site-specific formation of thyrotropin-releasing hormone-induced gastric ulcers through the vagal system. Scand J Gastroenterol 1994; 29: 226-31.
35. Henagan JM, Smith GS, Seidel ER, Miller TA. Influence of vagotomy on mucosal protection against alcohol-induced gastric damage in the rat. Gastroenterology 1984; 87: 903-8.
36. Mozsik G, Kiraly A, Garamszegi M, et al. Failure of prostacyclin, beta-carotene, atropine and cimetidine to produce gastric cyto-and general mucosal protection in surgically vagotomized rats. Life Sci 1991; 49: 1383-9.
37. Tache Y. Brainstem neuropeptides and vagal protection of the gastric mucosal against injury: role of prostaglandins, nitric oxide and calcitonin-gene related Peptide in capsaicin afferents. Curr Med Chem 2012; 19: 35-42.
38. Brzozowska I, Ptak-Belowska A, Pawlik M, et al. Mucosal strengthening activity of central and peripheral melatonin in the mechanism of gastric defense. J Physiol Pharmacol 2009; 60 Suppl 7: 47-56.
39. Brzozowski T, Konturek PC, Sliwowski Z, et al. Neural aspects of ghrelin-induced gastroprotection against mucosal injury induced by noxious agents. J Physiol Pharmacol 2006; 57 Suppl 6: 63-76.
40. Brzozowski T, Konturek PC, Pajdo R, et al. Brain-gut axis in gastroprotection by leptin and cholecystokinin against ischemiareperfusion induced gastric lesions. J Physiol Pharmacol 2001; 52: 583-602.
41. Gyires K. Neuropeptides and gastric mucosal homeostasis. Curr Top Med Chem 2004; 4: 63-73.
42. Gyires K. Gastric mucosal protection: from prostaglandins to genetherapy. Curr Med Chem 2005; 12: 203-15.
43. Shujaa N, Zadori ZS, Ronai AZ, et al. Analysis of the effect of neuropeptides and cannabinoids in gastric mucosal defense initi ated centrally in the rat. J Physiol Pharmacol 2009; 60 Suppl 7: 93-100.
44. Holzer P, Lippe IT. Stimulation of afferent nerve endings by intragastric capsaicin protects against ethanol-induced damage of gastric mucosa. Neuroscience 1988; 27: 981-7.
45. Holzer P, Pabst MA, Lippe IT, et al. Afferent nerve-mediated protection against deep mucosal damage in the rat stomach. Gastroenterology 1990; 98: 838-48.
46. Kato K, Matsuno Y, Matsuo Y, et al. Role of mucosal prostaglandins in vagally-mediated adaptive cytoprotection in the rat. Gastroenterol Jpn 1992; 27: 1-8.
47. Yoneda M, Tache Y. Central thyrotropin-releasing factor analog prevents ethanol-induced gastric damage through prostaglandins in rats. Gastroenterology 1992; 102: 1568-74.
48. Zhang YM, Wei EQ, Hu X, Xu M, Shi Y, Zhang JF. Administration of angiotensin II in the paraventricular nucleus protects gastric mucosa from ischemia-reperfusion injury. Brain Res 2008; 1212: 25-34.
49. Polidori C, Massi M, Guerrini R, Grandi D, Lupo D, Morini G. Peripheral mechanisms involved in gastric mucosal protection by intracerebroventricular and intraperitoneal nociceptin in rats. Endocrinology 2005; 146: 3861-7.
50. Fodor M, Pammer C, Gorcs T, Palkovits M. Neuropeptides in the human dorsal vagal complex: an immunohistochemical study. J Chem Neuroanat 1994; 7: 141-57.
51. Leslie RA. Neuroactive substances in the dorsal vagal complex of the medulla oblongata: nucleus of the tractus solitarius, area postrema, and dorsal motor nucleus of the vagus. Neurochem Int 1985; 7: 191-211.
52. Ferri S, Arrigo-Reina R, Candeletti S, et al. Central and peripheral sites of action for the protective effect of opioids of the rat stomach. Pharmacol Res Commun 1983; 15: 409-18.
53. Glavin GB. Effects of morphine and naloxone on restraint-stress ulcers in rats. Pharmacology 1985; 31: 57-60.
54. Gyires K, Ronai AZ. Supraspinal delta-and mu-opioid receptors mediate gastric mucosal protection in the rat. J Pharmacol Exp Ther 2001; 297: 1010-5.
55. Gyires K, Mullner K, Ronai AZ. Activation of central opioid receptors may induce gastric mucosal defence in the rat. J Physiol Paris 2001; 95: 189-96.
56. Scoto GM, Parenti C. Prevention of stress-induced gastric ulcers by mu-and delta-opioid agonists in the rat. J Physiol Paris 1993; 87: 385-8.
57. Gyires K, Ronai AZ, Mullner K, Furst S. Intracerebroventricular injection of clonidine releases beta-endorphin to induce mucosal protection in the rat. Neuropharmacology 2000; 39: 961-8.
58. Ronai AZ, Gyires K, Barna I, Mullner K, Palkovits M. Neonatal monosodium glutamate treatment abolishes both delta opioid receptor-induced and alpha-2 adrenoceptor-mediated gastroprotection in the lower brainstem in rats. J Physiol Paris 2001; 95: 215-20.
59. Zadori ZS, Shujaa N, Koles L, Kiraly KP, Tekes K, Gyires K. Nocistatin and nociceptin given centrally induce opioid-mediated gastric mucosal protection. Peptides 2008; 29: 2257-65.
60. Zadina JE, Hackler L, Ge LJ, Kastin AJ. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 1997; 386: 499-502.
61. Martin-Schild S, Gerall AA, Kastin AJ, Zadina JE. Differential distribution of endomorphin 1-and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol 1999; 405: 450-71.
62. Hosohata K, Burkey TH, Alfaro-Lopez J, et al. Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptor. Eur J Pharmacol 1998; 346: 111-4.
63. Sim LJ, Liu Q, Childers SR, Selley DE. Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors. J Neurochem 1998; 70: 1567-76.
64. Kiraly K, Szalay B, Szalai J, et al. Intrathecally injected Ile-Pro-Ile, an inhibitor of membrane ectoenzyme dipeptidyl peptidase IV, is antihyperalgesic in rats by switching the enzyme from hydrolase to synthase functional mode to generate endomorphin 2. Eur J Pharmacol 2009; 620: 21-6.
65. Ronai AZ, Kiraly K, Szebeni A, et al. Immunoreactive endomorphin 2 is generated extracellularly in rat isolated L4,5 dorsal root ganglia by DPP-IV. Regul Pept 2009; 157: 1-2.
66. Fichna J, Janecka A, Costentin J, Do Rego JC. The endomorphin system and its evolving neurophysiological role. Pharmacol Rev 2007; 59:88-123.
67. Horvath G. Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous mu-opioid receptor agonists. Pharmacol Ther 2000; 88: 437-63.
68. Fichna J, Perlikowska R, Gach K, et al. The novel endomorphin degradation blockers Tyr-Pro-DClPhe-Phe-NH (EMDB-1) and Tyr-Pro-Ala-NH (EMDB-2) prolong endomorphin-2 action in rat ileum in vitro. Chem Biol Drug Des 2010; 76: 77-81.
69. Goldberg IE, Rossi GC, Letchworth SR, et al. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J Pharmacol Exp Ther 1998; 286: 1007-13.
70. Storr M, Gaffal E, Schusdziarra V, Allescher HD. Endomorphins 1 and 2 reduce relaxant non-adrenergic, non-cholinergic neurotransmission in rat gastric fundus. Life Sci 2002; 71: 383-9.
71. Tonini M, Fiori E, Balestra B, et al. Endomorphin-1 and endomorphin-2 activate mu-opioid receptors in myenteric neurons of the guinea-pig small intestine. Naunyn Schmiedebergs Arch Pharmacol 1998; 358: 686-9.
72. Yokotani K, Osumi Y. Involvement of mu-receptor in endogenous opioid peptide-mediated inhibition of acetylcholine release from the rat stomach. Jpn J Pharmacol 1998; 78: 93-5.
73. Hui R, Chen T, Li YQ. The reciprocal connections of endomorphin 1-and endomorphin 2-containing neurons between the hypothalamus and nucleus tractus solitarii in the rat. Neuroscience 2006; 138: 171-81.
74. Mansour A, Fox CA, Akil H, Watson SJ. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 1995; 18: 22-9.
75. Gyires K, Zadori Z. Analysis of central mechanisms involved in gastric mucosal integrity. Neuropsychopharmacol Hung 2008; 10: 121-5.
76. Hackler L, Zadina JE, Ge LJ, Kastin AJ. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Peptides 1997; 18: 1635-9.
77. Shane R, Wilk S, Bodnar RJ. Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV. Brain Res 1999; 815: 278-86.
78. Tomboly C, Peter A, Toth G. In vitro quantitative study of the degradation of endomorphins. Peptides 2002; 23: 1573-80.
79. Sakurada C, Sakurada S, Hayashi T, Katsuyama S, Tan-No K, Sakurada T. Degradation of endomorphin-2 at the supraspinal level in mice is initiated by dipeptidyl peptidase IV: an in vitro and in vivo study. Biochem Pharmacol 2003; 66: 653-61.
80. Ronai AZ, Timar J, Mako E, et al. Diprotin A, an inhibitor of dipeptidyl aminopeptidase IV(EC 3.4.14.5) produces naloxonereversible analgesia in rats. Life Sci 1999; 64: 145-52.
81. Mentlein R. Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides. Regul Pept 1999; 85: 9-24.
82. Yang H, Kawakubo K, Tache Y. Intracisternal PYY increases gastric mucosal resistance: role of cholinergic, CGRP, and NO pathways. Am J Physiol 1999; 277: 555-62.
83. Yoneda M, Nakamura K, Yokohama S, et al. Neuropeptide Y stimulates bile secretion via Y1 receptor in the left dorsal vagal complex in rats. Hepatology 1998; 28: 670-6.
84. Mercer DW, Ritchie WP, Jr., Dempsey DT. Sensory neuronmediated gastric mucosal protection is blocked by cyclooxygenase inhibition. Surgery 1994; 115: 156-63.
85. Tache Y, Yoneda M, Kato K, Kiraly A, Suto G, Kaneko H. Intracisternal thyrotropin-releasing hormone-induced vagally mediated gastric protection against ethanol lesions: central and peripheral mechanisms. J Gastroenterol Hepatol 1994; 9 Suppl 1: 29-35.
86. Wallace JL, McKnight GW, Befus AD. Capsaicin-induced hyperemia in the stomach: possible contribution of mast cells. Am J Physiol 1992; 263: 209-14.
87. Bunnett NW, Helton WS, Debas HT, Ensinck JW. CGRP stimulates the release of pro-somatostatin-derived peptides from the gastric fundus. Am J Physiol 1990; 258: 316-9.
88. Koop H, Eissele R, Kuhlkamp V, Bothe E, Dionysius J, Arnold R. Calcitonin gene-related peptide stimulates rat gastric somatostatin release in vitro. Life Sci 1987; 40: 541-6.